Traws Pharma, Inc.

Q4 2025 13F Holders

Symbol
TRAW
CUSIP
68232V884
Type
Equity
Class
COM NEW
Num filings
22
Total reported value, excl. options
$3.86 M
Manager Report Date Value ($000) Shares Option Type